Business ❯Pharmaceutical Industry ❯Drug Development

Clinical Trials

Market Impact Eli Lilly Market Competition Psychedelic Companies Cytokinetics AstraZeneca Gilead Sciences Product Recall Mounjaro Mounjaro Impact Pfizer's weight-loss pill candidates HIV Prevention Drugs Zepbound Regulatory Compliance Innovative Treatments Novo Nordisk AIO-001 Hi1a Drug Trial Results Aduhelm Study Obesity Treatment Liver Disease Treatment Vertex Pharmaceuticals Phase II Trials Competition Among Companies

Parkinson’s and RLS Drug Linked to Risky Impulse Behaviors

Patients report compulsive gambling and hypersexuality tied to dopamine agonist medication, with claims of inadequate warnings from doctors.

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

Nurse's Death Linked to NHS-Approved Weight-Loss Drug Mounjaro

Pfizer Withdraws Sickle Cell Drug Oxbryta Over Safety Concerns

Lenacapavir Injection Shows 96% Efficacy in Preventing HIV

AstraZeneca Under Chinese Compliance Probe; Lung Cancer Drug Trial Results Disappoint

Eli Lilly's Zepbound Shows Promise in Reducing Heart Failure Risks

Gilead's Lenacapavir Shows 100% Efficacy in HIV Prevention Trial

Viking Therapeutics' New Weight Loss Drug Shows Promising Trial Results

Gilead's Trodelvy Fails in Lung Cancer Trial, Stock Drops Over 10%

Spider Venom Molecule Shows Promise in Treating Heart Attacks and Strokes

GSK Acquires Aiolos Bio in $1.4 Billion Deal